Pharmasset, Inc. - Investor Relations

www.Pharmasset.com

May 22, 2008 03:57 PM

Investor Relations

Press Releases

Events & Presentations

Corporate Governance

Financial Information

Search Investor Relations

Investor Relations

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Pharmasset, Inc. 's financial performance into perspective.

Stock Quote

NASDAQ : VRUS
$17.65

0.25

As of May 22, 2008 at 3:40 PM ET

Quotes delayed at least 20 minutes. Information provided by TurboFeed.

Recent Releases

May 19, 2008
Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C

May 15, 2008
Pharmasset Reports Financial Results for Quarter Ended March 31, 2008

View all releases »

Investor Relations Contact

Alan S. Roemer, MBA, MPH
Vice President, Investor Relations & Corporate Communications
Phone: (609) 613-4125
Email

Site Design by Lakeshore Concepts